Isobutyramide | |
---|---|
Trade Name | |
Orphan Indication | Sickle cell anemia |
USA Market Approval | USA |
USA Designation Date | 1994-05-25 00:00:00 |
Sponsor | Alpha Therapeutic Corporation;5555 Valley Boulevard;Los Angeles, California, 90032 |
Related Access Program